China SXT Pharmaceuticals, Inc. (SXTC) stock
SXTCNasdaqPharmaceutical PreparationsFiscal year ends March 31
$2.86−0.13 (-4.35%)
Close on Nov 17, 2026Market cap $2.74MP/E –Yield –
China SXT Pharmaceuticals operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
For fiscal 2026 it was -$4.02M. The highest annual figure on record is $1.92M in fiscal 2018.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | -$4.02M | – |
| FY2025 | Mar 31, 2025 | -$2.35M | – |
| FY2024 | Mar 31, 2024 | -$1.93M | – |
| FY2023 | Mar 31, 2023 | -$80.76K | -130.1% |
| FY2022 | Mar 31, 2022 | $268.29K | – |
| FY2021 | Mar 31, 2021 | -$1.32M | -240.9% |
| FY2020 | Mar 31, 2020 | $934.25K | +290.6% |
| FY2019 | Mar 31, 2019 | $239.19K | -87.5% |
| FY2018 | Mar 31, 2018 | $1.92M | +555.3% |
| FY2017 | Mar 31, 2017 | $293.04K | – |
See a number that looks wrong?